Population
Two brothers of Turkish descent with familial Type I hyperlipoproteinemia, normal plasma apolipoprotein C-II…
Comparison
In vitro expression of mutant lipoprotein lipases vs In vitro expression of wild type lipoprotein…
Design
Preclinical
Authors
Loading...
Asp156Gly abolishes LPL activity in models; supports variant classification but leaves open clinical genetic testing utility.
The Asp156->Gly mutation in the catalytic triad of lipoprotein lipase abolishes enzyme activity and causes familial Type I hyperlipoproteinemia, while the Ser447->Ter nonsense mutation is a benign polymorphism.
Faustinella et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: